NASDAQ: IRIX
Iridex Corp Stock

$1.79-0.01 (-0.56%)
Updated Nov 29, 2024
IRIX Price
$1.79
Fair Value Price
N/A
Market Cap
$29.78M
52 Week Low
$1.27
52 Week High
$3.65
P/E
-2.67x
P/B
11.35x
P/S
0.61x
PEG
N/A
Dividend Yield
N/A
Revenue
$48.43M
Earnings
-$11.04M
Gross Margin
38.8%
Operating Margin
-22.51%
Profit Margin
-22.8%
Debt to Equity
10.5
Operating Cash Flow
-$7M
Beta
0.87
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

IRIX Overview

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine IRIX's potential to beat the market

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
C
IRIX
Ranked
Unranked of 90

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$30.78A
$12.29A
$19.54A
View Top Medical Device Stocks

Be the first to know about important IRIX news, forecast changes, insider trades & much more!

IRIX News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IRIX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IRIX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IRIX is poor value based on its book value relative to its share price (11.35x), compared to the US Medical Devices industry average (4.13x)
P/B vs Industry Valuation
IRIX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more IRIX due diligence checks available for Premium users.

Valuation

IRIX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-2.67x
Industry
37.55x
Market
27.74x

IRIX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
11.35x
Industry
4.13x
IRIX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IRIX's financial health

Profit margin

Revenue
$11.6M
Net Income
-$1.9M
Profit Margin
-16.7%
IRIX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
IRIX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$30.2M
Liabilities
$27.5M
Debt to equity
10.5
IRIX's short-term assets ($24.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IRIX's short-term assets ($24.34M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IRIX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
IRIX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.1M
Investing
-$1.0k
Financing
$2.8M
IRIX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IRIX vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
IRIX$29.78M-0.56%-2.67x11.35x
CODX$28.45M-4.81%-0.65x0.45x
BSGM$31.54M+2.23%-1.28x-77.88x
NSYSC$31.98M+11.64%6.95x0.90x
IINN$24.89M+0.75%-1.75x4.66x

Iridex Stock FAQ

What is Iridex's quote symbol?

(NASDAQ: IRIX) Iridex trades on the NASDAQ under the ticker symbol IRIX. Iridex stock quotes can also be displayed as NASDAQ: IRIX.

If you're new to stock investing, here's how to buy Iridex stock.

What is the 52 week high and low for Iridex (NASDAQ: IRIX)?

(NASDAQ: IRIX) Iridex's 52-week high was $3.65, and its 52-week low was $1.27. It is currently -50.96% from its 52-week high and 40.72% from its 52-week low.

How much is Iridex stock worth today?

(NASDAQ: IRIX) Iridex currently has 16,636,380 outstanding shares. With Iridex stock trading at $1.79 per share, the total value of Iridex stock (market capitalization) is $29.78M.

Iridex stock was originally listed at a price of $7.63 in Dec 31, 1997. If you had invested in Iridex stock at $7.63, your return over the last 26 years would have been -76.52%, for an annualized return of -5.42% (not including any dividends or dividend reinvestments).

How much is Iridex's stock price per share?

(NASDAQ: IRIX) Iridex stock price per share is $1.79 today (as of Nov 29, 2024).

What is Iridex's Market Cap?

(NASDAQ: IRIX) Iridex's market cap is $29.78M, as of Dec 2, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Iridex's market cap is calculated by multiplying IRIX's current stock price of $1.79 by IRIX's total outstanding shares of 16,636,380.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.